Oncology

Who Will Benefit From Metformin?

2022.05.24 / Joanne E Mortimer

Neoadjuvant Programmed Cell Death Protein 1 and Chemotherapy in Combination in Muscle-Invasive Urothelial Cancer: Promising, But Not Deserving to Try Further

2022.05.24 / Sheng Zhang

Warm Companion

2022.05.24 / Meaghann S Weaver

Reply to S. Zhang

2022.05.24 / Michael Lattanzi

Complementary Approaches to Lung Cancer Detection in High-Risk Populations

2022.05.23 / M Patricia Rivera

Association of neutrophil-to-lymphocyte ratio, radiotherapy fractionation/technique, and risk of development of distant metastasis among patients with locally advanced rectal cancer

2022.05.21 / Gowoon Yang

Germline Mutations Related to Primary Hyperparathyroidism Identified by Next-Generation Sequencing

2022.05.19 / Hye-Sun Park

Risk factors and economic burden of postoperative anastomotic leakage related events in patients who underwent surgeries for colorectal cancer

2022.05.18 / Jeonghyun Kang

Cytogenetic testing by fluorescence in situ hybridization is improved by plasma cell sorting in multiple myeloma

2022.05.18 / Jihye Ha

Long-term clinical course and progression of lymphangioleiomyomatosis in a single lung transplant referral centre in Korea

2022.05.18 / Shihwan Chang

Underrecognition of Symptoms Caused by Breast Radiation Therapy

New Prevalence Data on Monoclonal Gammopathies

BRCA1 and BRCA2: Risk Beyond Breast and Ovarian Cancer

Do Advance Directives Undermine Advance Care Planning?

Segmentectomy Is Supported as Standard of Care for Small, Peripheral Non–Small-Cell Lung Cancer